[Miocamycin in the prevention and treatment of cutaneous infections in the emergency service].
The efficacy and tolerability of a new macrolide, Myocamycine, were assessed in the anti-infectious prophylaxis of lacerations and contusions and in the treatment of already infected wounds or phlegmons. A total of 175 patients were treated. Side effects induced the suspension of treatment in 8% of cases while the drug proved effective in preventing the infection of wounds at risk in 98% and curing existing infections in 100%.